首页>
外国专利>
Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome
Nonselective metabotropic glutamate receptor activators for treatment of attention deficit disorder and 22Q syndrome
展开▼
机译:非选择性代谢型谷氨酸受体激活剂,用于治疗注意力缺陷症和22Q综合征
展开▼
页面导航
摘要
著录项
相似文献
摘要
This application relates to methods of treating attention deficit hyperactivity disorder (ADHD), 22q deletion and/or duplication syndrome, and co-morbidities with a nonselective activator of metabotropic glutamate receptors, such as fasoracetam, for example, in subjects having a genetic alteration in at least one metabotropic glutamate receptor (mGluR) network gene.
展开▼